Regulus Therapeutics
Why Robinhood?
You can watch RGLS and buy or sell other stocks, ETFs, and their options commission-free!About RGLS
Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development.
RGLS Key Statistics
Stock Snapshot
As of today, Regulus Therapeutics(RGLS) shares are valued at $8.16. The company's market cap stands at 1.19B.
On 2026-07-25, Regulus Therapeutics(RGLS) stock opened at —, reached a high of —, and a low of —.
Regulus Therapeutics(RGLS) shares are trading with a volume of 0, against a daily average of 1.25M.
In the last year, Regulus Therapeutics(RGLS) shares hit a 52-week high of $0.87 and a 52-week low of $0.16.
In the last year, Regulus Therapeutics(RGLS) shares hit a 52-week high of $0.87 and a 52-week low of $0.16.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.